.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
UB GOOD is stocked at 119 licensed dispensaries across Ohio, Maryland, and Nevada, 103 of them in Ohio, with the deepest coverage in Columbus, Cincinnati, Cleveland, Dayton, and Akron. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
UB GOOD’s mix in September 2026 tilted toward Edible at 46.85% share (ranked 1 in Edible), while Vapor Pens held 36.29% share; Edible grew 46.15% year over year and 12.30% month over month, whereas Vapor Pens surged 77.03% year over year but slipped 0.05% month over month. Tincture & Sublingual contributed 9.30% share with 32.59% year-over-year growth and 8.87% month-over-month growth, and Capsules rose to 6.63% share with 55.38% year-over-year growth and a 46.14% month-over-month jump. Concentrates remained a niche at 0.69% share with 34.49% year-over-year and 14.49% month-over-month gains, while Topical contracted to 0.25% share with a -40.00% year-over-year decline despite a 7.28% month-over-month uptick. The pattern implies UB GOOD is consolidating around two engines—Edible stability and Vapor Pens acceleration—while Capsules emerges as a third lever given its outsized month-over-month spike and higher average price, positioning the brand to trade mix toward faster-growing, mid-to-premium formats even as Topical retreats.
With average price down 9.83% year over year to $24.91 and Edible’s average price at $22.78 versus Vapor Pens at $25.16, UB GOOD is leaning into price-accessible volume in Edible while protecting margin potential via higher-priced Capsules at $31.69 and Tincture & Sublingual at $33.07; this sets a barbell pricing posture that can expand reach without compressing mix economics. Holding the number 1 rank in Edible in Ohio while Vapor Pens posts 77.03% year-over-year growth suggests headroom to translate category leadership into cross-category pull, and the 46.14% month-over-month increase in Capsules indicates white space for targeted line extensions. The implication is a deliberate shift toward a two-tiered mix—defensive volume in Edible paired with growth optionality in Vapor Pens and Capsules—aimed at sustaining the 54.25% brand sales year-over-year pace while moderating price declines through mix upweighting in higher-priced subcategories.
Competitive Landscape
UB GOOD is ranked #1 in Ohio Edible in September 2026 after rising 1 position year over year from #2, and it moved up 2 positions since June 2026 when it sat at #3; this ascent to a new peak in September 2026 coincides with Incredibles slipping 1 position from #1 to #2 despite a 35.41% YoY sales increase, while Gron / Grön climbed 5 ranks from #8 to #3 on 111.47% YoY growth and Smokiez Edibles improved 1 spot from #5 to #4 with 22.75% YoY growth; this pattern implies UB GOOD’s rank trajectory is driven more by relative share capture and competitor displacement than by category-wide expansion, and that maintaining #1 will require defending against fast rank gainers like Gron / Grön.
Notable Products
CBN/THC 1:1 Razzzberry Gummies 10-Pack (100mg CBN, 100mg THC) posted the standout movement in September 2026 with a 53.6% MoM gain to rank 4, while Cherry Pomegranate Extra Strength Releaf Gummies 10-Pack (500mg) rose 24.4% to hold rank 1. Pineapple Punch Extra Strength Gummies 10-Pack (500mg) advanced 12.8% at rank 2, and Sativa Kiwi Dragonfruit Boost Gummies 10-Pack (100mg) climbed 38.7% at rank 3, marking a stack of MoM increases concentrated in the top three ranks. With four of the top ten being Vapor Pens that each grew between 17.4% and 19.5% yet sitting at ranks 5, 9, and 10, the hierarchy still tilts toward Edibles despite cross-category momentum. The mix implies UB GOOD is consolidating an Edibles-led lead while nurturing a secondary growth lane in Vapor Pens, positioning the brand to lean on high-MoM functional gummies as the demand anchor.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
